U.S. Ambulatory Surgery Center Market Hits $49.19 Billion in 2026 as Outpatient Migration Accelerates

The U.S. ambulatory surgery center (ASC) market has reached a valuation of $49.19 billion in 2026, marking a significant phase of expansion as healthcare providers, physicians, payers, and investors accelerate the migration of appropriate surgical procedures to lower-cost outpatient settings. The market is projected to grow to $84.17 billion by 2035, representing a compound annual growth rate (CAGR) of 6.15% from 2026 to 2035, according to a new report by Precedence Research.

This growth is driven by a confluence of factors, including the ongoing shift of procedures from inpatient hospitals to outpatient ASCs, which offer cost savings and convenience. Additionally, ASCs are increasingly handling higher-acuity cases, expanding their scope of services. The sector is also experiencing consolidation, as investors and large healthcare systems acquire independent centers to gain economies of scale and negotiate better payer contracts. The report highlights that these trends are reshaping the U.S. surgical care landscape.

The implications are far-reaching: patients may benefit from lower out-of-pocket costs and more accessible care, while payers and providers seek efficiencies. However, challenges such as regulatory hurdles, workforce shortages, and the need for robust quality metrics remain. As the market continues to evolve, stakeholders will need to adapt to the changing dynamics, with further consolidation and investment expected in the coming years.